Price target
28.700.000.00%
The 13 analysts offering 1 year price forecasts for TKD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to TKD in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TKD EPS for the last quarter is 0.36 EUR despite the estimation of 0.23 EUR. In the next quarter EPS is expected to reach 0.20 EUR. Track more of TAKEDA PHARM.CO.LTD. financials and stay on top of what is up with the company.
In the next quarter TAKEDA PHARM.CO.LTD. revenue is expected to reach 7.12 B EUR. Check out TAKEDA PHARM.CO.LTD. revenue and earnings and make informed decisions.
According to analysts, TKD price target is 28.70 EUR with a max estimate of 36.01 EUR and a min estimate of 25.64 EUR. Check if this forecast comes true in a year, meanwhile watch TAKEDA PHARM.CO.LTD. stock price chart and keep track of the current situation with TKD news and stock market news.
We've gathered opinions of 15 analysts rating TKD stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.